1. Volume 9, Issue 1, Pages 27-32 (October 2002)
Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model 
Petr Dobšák, J Siegelova, J.E Wolf, L Rochette, J.C Eicher, J Vasku, S Kuchtickova, M Horky 
Pathophysiology 
Volume 9, Issue 1, Pages (October 2002)
DOI: /S (02)

2. Fig. 1
Effect of DFX on cardiac output (ml/min per g of wet heart) during preischemic period and reperfusion. Results are expressed as the mean±S.D. (□ controls, ■ DFX 50 μM, **P<0.01; ***P<0.001).
Pathophysiology 2002 9, 27-32DOI: ( /S (02) )

3. Fig. 2
Detection of apoptotic cardiomyocytes using TdT-mediated biotin–dUTP nick-end labeling (TUNEL) technique in the group “DFX 50 μM” (a) and the group “controls” (b). Arrows indicate examples of apoptotic cardiomyocytes (magnification 100×, counterstaining with hematoxyline).
Pathophysiology 2002 9, 27-32DOI: ( /S (02) )

4. Fig. 3
Percentage of nuclei staining positive for TUNEL in heart tissue samples after 4 h of global cold ischemia and 45 min of reperfusion in the group “DFX 50 μM” and the group “controls”. (DFX=deferoxamine, *P<0.05 vs. group “controls”).
Pathophysiology 2002 9, 27-32DOI: ( /S (02) )

5. Pathophysiology 2002 9, 27-32DOI: (10.1016/S0928-4680(02)00054-8)

6. Pathophysiology 2002 9, 27-32DOI: (10.1016/S0928-4680(02)00054-8)